Background & Aims: Broadly reactive neutralizing antibodies (nAbs) and multispecific T-cell responses are generated during chronic hepatitisC virus (HCV) infection and yet fail to clear the virus.
Objective: The aim of this study was to evaluate the relationship between anti-interferon antibodies (anti-IFN Ab) and the therapeutic effect of interferon (IFN) in patients with chronic hepatitisC.